Bilge Esin Ozturk

Title: Bilge Esin Ozturk: Innovator in Gene Therapy

Introduction

Bilge Esin Ozturk is a notable inventor based in Pittsburgh, PA. He has made significant contributions to the field of gene therapy, particularly through his innovative patent work. His research focuses on the development of novel conjugates that utilize Adeno-Associated Viruses (AAVs) in combination with CAS9 polypeptides.

Latest Patents

Ozturk holds a patent for "Conjugates comprising AAVs and CAS9 polypeptides." This invention provides an AAV that features an exterior surface with peptide tags that bond with a binding-partner. The AAV is characterized as a live virus. The patent also describes a conjugate that includes at least one AAV and a polypeptide with a binding-partner domain and a bioactive polypeptide domain. Additionally, it outlines a conjugate comprising two AAVs, where the second AAV has a surface that includes a binding-partner for the tag or a linker molecule.

Career Highlights

Ozturk has worked at prestigious institutions, including the University of California and the University of Pittsburgh. His experience in these research environments has allowed him to advance his work in gene therapy and contribute to the scientific community.

Collaborations

Ozturk has collaborated with notable colleagues, including Leah C Byrne and Timothy P Day. These partnerships have likely enriched his research and contributed to the success of his innovative projects.

Conclusion

Bilge Esin Ozturk is a pioneering inventor whose work in gene therapy has the potential to impact medical science significantly. His patent on AAV and CAS9 polypeptide conjugates showcases his innovative approach to addressing complex biological challenges.